Synergistically enhanced immunosuppressive effect by combined use of cyclosporine and mizoribine.
Amemiya
H
H
National Cardiovascular Center, Research Institute, Osaka, Japan.
Suzuki
S
S
Watanabe
H
H
Hayashi
R
R
Niiya
S
S
D000818:Animals; D003524:Cyclosporins / Q000627:therapeutic use*; D004285:Dogs; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D006085:Graft Survival / Q000187:drug effects*; D016027:Heart Transplantation; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation; D009206:Myocardium / Q000473:pathology; D012263:Ribonucleosides / Q000627:therapeutic use*; D014184:Transplantation, Homologous / Q000379:methods
D003524:Cyclosporins; D007166:Immunosuppressive Agents; D012263:Ribonucleosides; C010052:mizoribine